Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Big pharma eyes Australian biotech as $300b patent cliff looms
When Swiss pharmaceutical giant Novartis paid more than $2 billion for cancer therapy company Myricx last month, it was a wake-up call for Australian venture capital and superannuation funds which have had mixed luck with the notoriously risky…
Fosun Pharma sells 4.55% stake in Gland Pharma for Rs 2,121 crore
Chinese pharmaceutical major Fosun Pharma has pared its holding in Gland Pharma by selling a 4.5 per cent stake for Rs 2,121 crore through separate block deals on BSE. Fosun Pharma Industrial Pte Ltd, one of the promoters of Gland Pharma, offloaded…
Chinese pharma major sells 4.55% Gland Pharma stake for ₹2,121cr
What's the story Fosun Pharma, a leading Chinese pharmaceutical company, has sold a 4.55% stake in Hyderabad -based Gland Pharma for ₹2,121.50 crore. The sale was executed through multiple block deals on the Bombay Stock Exchange (BSE).
Bank of New York Mellon Corp Buys New Position in Urogen Pharma $URGN
Bank of New York Mellon Corp purchased a new position in shares of Urogen Pharma (NASDAQ:URGN - Free Report) during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional…
The Kratom Conspiracy: Why Big Pharma Wants to Ban Nature's Answer to Opioids
n the 1930s, a coordinated campaign of racist propaganda and corporate greed turned a revered medicinal plant into a Schedule I “drug” with no recognized medical value. The target was cannabis. The architects were lumber baron William…
Here's Why Billionaires Stanley Druckenmiller and Ken Griffin Are Loading Up on Eli Lilly Stock
The adage that 'birds of a feather flock together' doesn't always apply to billionaire investors. Most of these super-successful individuals have their own unique strategies that are highly differentiated from other approaches. However, that…
Novartis India to pursue therapy-aligned acquisitions; eyes expansion in Tier 2 and Tier 3 markets
Pharma company Novartis India Ltd (NIL) plans to pursue disciplined, therapy-aligned acquisitions and deepen its last-mile reach into Tier 2 and Tier 3 markets to drive its next phase of growth, according to the company's annual report. The…
Rose Capital Advisors LLC Invests $905,000 in Pfizer Inc. $PFE
Rose Capital Advisors LLC acquired a new stake in Pfizer Inc. (NYSE:PFE - Free Report) in the second quarter, according to the company in its most recent filing with the SEC. The firm acquired 37,580 shares of the biopharmaceutical company's stock…
Financial analyst on ECB hike: Interest rates are rising... what should you do?
DONE WELL, CENTRAL banking is pretty bland stuff. No surprises. Such is the case for next week's European Central Bank announcement on interest rates. The people in grey suits are scheduled to spend two days in meetings, emerging at lunchtime on…
All the doctors who have been banned or faced disciplinary action in 2026
As one of the most trusted professions in the country, doctors are watched closely by organisations such as the General Medical Council to ensure patients are safe and the profession is trusted. So far in 2026, the Medical Practitioners Tribunal…
B. Metzler seel. Sohn & Co. AG Has $153.79 Million Stock Holdings in Eli Lilly and Company $LLY
B. Metzler seel. Sohn & Co. AG lifted its position in Eli Lilly and Company (NYSE:LLY - Free Report) by 4.6% during the 2nd quarter, according to the company in its most recent filing with the SEC. The fund owned 128,222 shares of the company's…
Nykredit A S Takes Position in Eli Lilly and Company $LLY
Nykredit A S bought a new stake in Eli Lilly and Company (NYSE:LLY - Free Report) during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought…
Wall Street Zen Upgrades argenex (NASDAQ:ARGX) to Buy
argenex (NASDAQ:ARGX - Get Free Report) was upgraded by investment analysts at Wall Street Zen from a 'hold' rating to a 'buy' rating in a research report issued on Sunday, Wall Street Zen reports. 2 Ways to Play the Big Pharma Patent Cliff ARGX…
Nan Shan Life Insurance Co. Ltd. Sells 5,472 Shares of Eli Lilly and Company $LLY
Nan Shan Life Insurance Co. Ltd. reduced its stake in Eli Lilly and Company (NYSE:LLY - Free Report) by 34.9% during the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 10,214 shares of…
3 Dividend Kings Built to Keep Raising Your Income When Rates Rise
Rising rates create a specific, mechanical problem for dividend stocks: when risk-free yields climb, a payout has to fight bonds for the same investor dollar, and share prices of income names often slide even when the underlying business is fine.
Receive a Daily briefing on Pharma Industry News
Get Started